Symptom-centric view
Intentional product use issue
Substances reporting Intentional product use issue disproportionately — ranked by ROR.
showing 3 of 3
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
tretinoin Retin-A · Atralin | 6.3 [5.5–7.2] | 221 | injectables | new |
| 7.4 [7.2–7.6] | 6,976 | algemeen | new | |
| 7.4 [7.2–7.6] | 6,977 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).